|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nguyen KS, Neal JW and Wakelee H: Review
of the current targeted therapies for non-small-cell lung cancer.
World J Clin Oncol. 5:576–587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boolell V, Alamgeer M, Watkins DN and
Ganju V: The evolution of therapies in non-small cell lung cancer.
Cancers (Basel). 7:1815–1846. 2015. View Article : Google Scholar
|
|
4
|
Rovigatti U: Cancer modelling in the NGS
era - Part I: Emerging technology and initial modelling. Crit Rev
Oncol Hematol. 96:274–307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gottfried M, Keizman D, Mishaeli M and
Rabinovich NM: The current approach to advanced lung cancer.
Harefuah. 154:521–540. 2015.In Hebrew.
|
|
6
|
Wang Z, Li Y, Banerjee S and Sarkar FH:
Emerging role of Notch in stem cells and cancer. Cancer Lett.
279:8–12. 2009. View Article : Google Scholar :
|
|
7
|
Kristoffersen K, Villingshøj M, Poulsen HS
and Stockhausen MT: Level of Notch activation determines the effect
on growth and stem cell-like features in glioblastoma multiforme
neurosphere cultures. Cancer Biol Ther. 14:625–637. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jang MS, Miao H, Carlesso N, Shelly L,
Zlobin A, Darack N, Qin JZ, Nickoloff BJ and Miele L: Notch-1
regulates cell death independently of differentiation in murine
erythroleukemia cells through multiple apoptosis and cell cycle
pathways. J Cell Physiol. 199:418–433. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Zhao F, Lu J, Li T, Yang H, Wu C and
Liu Y: Notch-1 signaling promotes the malignant features of human
breast cancer through NF-κB activation. PLoS One. 9:e959122014.
View Article : Google Scholar
|
|
10
|
Leong KG and Karsan A: Recent insights
into the role of Notch signaling in tumorigenesis. Blood.
107:2223–2233. 2006. View Article : Google Scholar
|
|
11
|
Leong KG and Gao WQ: The Notch pathway in
prostate development and cancer. Differentiation. 76:699–716. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miele L and Osborne B: Arbiter of
differentiation and death: Notch signaling meets apoptosis. J Cell
Physiol. 181:393–409. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Li Y, Banerjee S and Sarkar FH:
Exploitation of the Notch signaling pathway as a novel target for
cancer therapy. Anticancer Res. 28:3621–3630. 2008.
|
|
14
|
Yin L, Velazquez OC and Liu ZJ: Notch
signaling: Emerging molecular targets for cancer therapy. Biochem
Pharmacol. 80:690–701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weaver KL, Alves-Guerra MC, Jin K, Wang Z,
Han X, Ranganathan P, Zhu X, DaSilva T, Liu W, Ratti F, et al: NACK
is an integral component of the Notch transcriptional activation
complex and is critical for development and tumorigenesis. Cancer
Res. 74:4741–4751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Androutsellis-Theotokis A, Leker RR,
Soldner F, Hoeppner DJ, Ravin R, Poser SW, Rueger MA, Bae SK,
Kittappa R and McKay RD: Notch signalling regulates stem cell
numbers in vitro and in vivo. Nature. 442:823–826. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bi P and Kuang S: Notch signaling as a
novel regulator of metabolism. Trends Endocrinol Metab. 26:248–255.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guruharsha KG, Kankel MW and
Artavanis-Tsakonas S: The Notch signalling system: Recent insights
into the complexity of a conserved pathway. Nat Rev Genet.
13:654–666. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Galluzzo P and Bocchetta M: Notch
signaling in lung cancer. Expert Rev Anticancer Ther. 11:533–540.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nickoloff BJ, Osborne BA and Miele L:
Notch signaling as a therapeutic target in cancer: A new approach
to the development of cell fate modifying agents. Oncogene.
22:6598–6608. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar
|
|
23
|
Wael H, Yoshida R, Kudoh S, Hasegawa K,
Niimori-Kita K and Ito T: Notch1 signaling controls cell
proliferation, apoptosis and differentiation in lung carcinoma.
Lung Cancer. 85:131–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang X, Zhou JH, Deng ZH, Qu XH, Jiang HY
and Liu Y: Expression and significance of Notch1, Jagged1 and VEGF
in human non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi
Xue Ban. 32:1031–1036. 2007.In Chinese.
|
|
25
|
Chen Y, De Marco MA, Graziani I, Gazdar
AF, Strack PR, Miele L and Bocchetta M: Oxygen concentration
determines the biological effects of NOTCH-1 signaling in
adenocarcinoma of the lung. Cancer Res. 67:7954–7959. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baumgart A, Seidl S, Vlachou P, Michel L,
Mitova N, Schatz N, Specht K, Koch I, Schuster T, Grundler R, et
al: ADAM17 regulates epidermal growth factor receptor expression
through the activation of Notch1 in non-small cell lung cancer.
Cancer Res. 70:5368–5378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ji X, Wang Z, Geamanu A, Sarkar FH and
Gupta SV: Inhibition of cell growth and induction of apoptosis in
non-small cell lung cancer cells by delta-tocotrienol is associated
with notch-1 down-regulation. J Cell Biochem. 112:2773–2783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eliasz S, Liang S, Chen Y, De Marco MA,
Machek O, Skucha S, Miele L and Bocchetta M: Notch-1 stimulates
survival of lung adenocarcinoma cells during hypoxia by activating
the IGF-1R pathway. Oncogene. 29:2488–2498. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Li D, Liu H, Xu H, Zheng H, Qian
F, Li W, Zhao C, Wang Z and Wang X: Notch-1 signaling facilitates
survivin expression in human non-small cell lung cancer cells.
Cancer Biol Ther. 11:14–21. 2011. View Article : Google Scholar
|
|
30
|
Manning G, Whyte DB, Martinez R, Hunter T
and Sudarsanam S: The protein kinase complement of the human
genome. Science. 298:1912–1934. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanaka H, Katoh H and Negishi M: Pragmin,
a novel effector of Rnd2 GTPase, stimulates RhoA activity. J Biol
Chem. 281:10355–10364. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nguyen TA and Fruehauf JH: Transkingdom
RNA interference (tkRNAi): A novel method to induce therapeutic
gene silencing. Methods Mol Biol. 514:27–34. 2009. View Article : Google Scholar
|
|
33
|
Geng J, Li X, Zhou Z, Wu CL, Dai M and Bai
X: EZH2 promotes tumor progression via regulating VEGF-A/AKT
signaling in non-small cell lung cancer. Cancer Lett. 359:275–287.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koff JL, Ramachandiran S and
Bernal-Mizrachi L: A time to kill: Targeting apoptosis in cancer.
Int J Mol Sci. 16:2942–2955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Drosopoulos K and Pintzas A: Multifaceted
targeting in cancer: The recent cell death players meet the usual
oncogene suspects. Expert Opin Ther Targets. 11:641–659. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Taylor K, Micha D, Ranson M and Dive C:
Recent advances in targeting regulators of apoptosis in cancer
cells for therapeutic gain. Expert Opin Investig Drugs. 15:669–690.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fischer A and Gessler M: Delta-Notch - and
then? Protein interactions and proposed modes of repression by Hes
and Hey bHLH factors. Nucleic Acids Res. 35:4583–4596. 2007.
View Article : Google Scholar :
|
|
38
|
Nakagawa O, McFadden DG, Nakagawa M,
Yanagisawa H, Hu T, Srivastava D and Olson EN: Members of the HRT
family of basic helix-loop-helix proteins act as transcriptional
repressors downstream of Notch signaling. Proc Natl Acad Sci USA.
97:13655–13660. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iso T, Kedes L and Hamamori Y: HES and
HERP families: Multiple effectors of the Notch signaling pathway. J
Cell Physiol. 194:237–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Al-Hussaini H, Subramanyam D, Reedijk M
and Sridhar SS: Notch signaling pathway as a therapeutic target in
breast cancer. Mol Cancer Ther. 10:9–15. 2011. View Article : Google Scholar
|
|
41
|
Candy PA, Phillips MR, Redfern AD, Colley
SM, Davidson JA, Stuart LM, Wood BA, Zeps N and Leedman PJ:
Notch-induced transcription factors are predictive of survival and
5-fluorouracil response in colorectal cancer patients. Br J Cancer.
109:1023–1030. 2013. View Article : Google Scholar : PubMed/NCBI
|
